Related references
Note: Only part of the references are listed.68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours
P. Mapelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? Comment
Ilaria Marinoni
GUT (2022)
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Wenzel M. Hackeng et al.
GUT (2022)
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
Fanny Orlhac et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
A Single-center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors
Stefano Partelli et al.
ANNALS OF SURGERY (2022)
Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies
Jemma Arakelyan et al.
CANCER (2021)
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
Paola Mapelli et al.
DIAGNOSTICS (2021)
Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
Fei Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
Matteo Tacelli et al.
ENDOSCOPIC ULTRASOUND (2021)
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases
Antonio Pea et al.
ANNALS OF SURGERY (2020)
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment
Paola Mapelli et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
Akira Toriihara et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States
Mi Ri Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
Mauro Cives et al.
SCIENTIFIC REPORTS (2019)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
Stefano Partelli et al.
NEUROENDOCRINOLOGY (2017)
Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors
Ummuhan Abdulrezzak et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade
Koji Takumi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
Michael S. Hofman et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
Massimo Falconi et al.
NEUROENDOCRINOLOGY (2012)